INTER-ACT: prevention of pregnancy complications through an e-health driven interpregnancy lifestyle intervention – study protocol of a multicentre randomised controlled trial
Adult
Interpregnancy lifestyle intervention
Study Protocol
Young Adult
03 medical and health sciences
0302 clinical medicine
Clinical Protocols
Maternal obesity
Behavior Therapy
Pregnancy
Humans
Exercise
Life Style
Gestational diabetes
Pregnancy Outcome
Prenatal Care
Gynecology and obstetrics
Excessive gestational weight gain
Telemedicine
Diet
3. Good health
Pregnancy Complications
Pregnancy-induced hypertension
RG1-991
Female
Human medicine
Risk Reduction Behavior
RCT
DOI:
10.1186/s12884-017-1336-2
Publication Date:
2017-05-26T09:55:16Z
AUTHORS (6)
ABSTRACT
Excessive maternal pre-pregnancy and gestational weight gain are related to pregnancy- birth outcomes. The interpregnancy time window offers a unique opportunity intervene in order acquire healthy lifestyle before the start of new pregnancy. INTER-ACT is an e-health driven multicentre randomised controlled intervention trial targeting women at high risk complications. Eligible recruited for study day 2 or 3 postpartum. At week 6 postpartum, participants into control arm study. focuses on weight, diet, physical activity mental well-being, comprises face-to-face coaching, which behavioural change techniques central, use mobile application, Bluetooth-connected weighing scale tracker. rolled out postpartum (4 coaching sessions between month 6) pregnancy (3 sessions, one each trimester pregnancy); app used throughout two phases. Data collection includes data from medical record (pregnancy outcomes history), anthropometric (height, waist- hip circumferences, skinfold thickness body composition by bio-electrical impedance analysis), (physical weight; group only) questionnaires (socio-demographics, breastfeeding, food intake, activity, lifestyle, psychosocial factors process evaluation). Medical collected inclusion delivery subsequent All other every months until pregnancy, Primary outcome composite endpoint score pregnancy-induced hypertension, diabetes mellitus, caesarean section, large-for-gestational-age infant its implementation pregnancies during with approach. ClinicalTrials.gov Identifier: NCT02989142 . Registered August 2016.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (54)
CITATIONS (36)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....